Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia corporate presentation may 2019 from adocia

Latest Press Releases

2019/05/07Number of shares and voting rights of ADOCIA as of April 30, 2019
2019/04/15Adocia announces the release of its Reference Document for the year 2018

All Press releases

Next events

May 20-23, 2019 TIDES: Oligonucleotide and Peptide Therapeutics, San Diego, CA, US - Adocia will make an oral presentation during this world's largest meeting dedicated to Oligonucleotide and Peptide Therapeutics.

All events

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.

Financial

Welcome to the investors section of Adocia

Interview of Gerard Soula and Valerie Danaguezian on French Financial Journal “Investir” – May 15th, 2019

Adocia Annual Shareholders’ Meeting next May 16, 2019 in Paris